CLINICAL_TRIALS
trial_result
· 2017-06-23
Clinical Trial Update: Efficacy and Tolerability of Topical LFX453 for External Genital Warts [Phase 2]
Summary
Phase 2 trial results for topical LFX453 show efficacy and tolerability in treating external genital warts.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: External Genital Warts | Phase 2 | Status: COMPLETED | Results posted: 2017-06-23